• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vivani Medical, Inc. - Common Stock (NQ: VANI )

    1.310 -0.130 (-9.03%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 198,050
    Open 1.430
    Bid (Size) 1.300 (2)
    Ask (Size) 1.320 (2)
    Prev. Close 1.440
    Today's Range 1.270 - 1.430
    52wk Range 0.8400 - 7.800
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results
    From Vivani Medical, Inc.
    Via Business Wire
    Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024
    From Vivani Medical, Inc.
    Via Business Wire

    Performance

    YTD
    +25.96%
    +25.96%
    1 Month
    +0.77%
    +0.77%
    3 Month
    -3.68%
    -3.68%
    6 Month
    -28.80%
    -28.80%
    1 Year
    +37.75%
    +37.75%

    More News

    Read More
    Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
    From Vivani Medical, Inc.
    Via Business Wire
    EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia
    Via Benzinga
    Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024
    From Vivani Medical, Inc.
    Via Business Wire
    Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant
    From Vivani Medical, Inc.
    Via Business Wire
    EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity
    Via Benzinga
    Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
    From Vivani Medical, Inc.
    Via Business Wire
    VANI Stock Earnings: Vivani Medical Beats EPS for Q2 2024
    Via InvestorPlace
    Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results
    From Vivani Medical, Inc.
    Via Business Wire
    Pineapple Financial And 1 Other Stock Under $1 Insiders Are Buying
    Via Benzinga
    Vivani Medical And 2 Other Stocks Under $2 Insiders Are Buying
    Via Benzinga
    Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115
    From Vivani Medical, Inc.
    Via Business Wire
    EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year
    Via Benzinga
    Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Why GLP-1 Developer Vivani Medical's Stock Is Climbing
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant
    From Vivani Medical, Inc.
    Via Business Wire
    EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's NDA Gains FDA Clearance For Clinical Use
    Via Benzinga
    Exposures Product Safety
    Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant
    From Vivani Medical, Inc.
    Via Business Wire
    EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use
    Via Benzinga
    VANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024
    Via InvestorPlace
    Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
    From Vivani Medical, Inc.
    Via Business Wire
    Vivani Medical to Present at TIDES Conference 2024
    From Vivani Medical, Inc.
    Via Business Wire
    VANI Stock Earnings: Vivani Medical Beats EPS for Q4 2023
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.